1852P Chronic cannabis used by patients with advanced cancer during Immunotherapy initiation: clinical outcomes and endocannabinoid levels evaluation

Autor:	Salvatore Campisi-Pinto, I. Choen, David Meiri, Ilit Turgeman, Gil Bar-Sela, Mor Moskovitz, Gil M. Lewitus, Avivit Peer, Paula Berman, Ayellet Jehassi, L. Oz-Ari, Mira Wollner, O. Vernicova
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty biology business.industry medicine.medical_treatment Hematology Immunotherapy biology.organism_classification Endocannabinoid system Advanced cancer Internal medicine medicine Cannabis business
Zdroj:	Annals of Oncology. 31:S1060-S1061
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.1499
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b72547d9e6cb75412d030fdc439104b6 https://doi.org/10.1016/j.annonc.2020.08.1499 Zobrazit plný text záznamu